more
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides
This article outlines standardized guidelines for developing N-of-1 exon skipping antisense oligonucleotides, emphasizing preclinical testing, ASO design, and data sharing.
